Orforglipron and Semaglutide Interaction

Avoid
Researched 95% confidence

Orforglipron and Semaglutide have a potentially harmful interaction with 95% confidence. Both are GLP-1 agonists; combining increases severe hypoglycemia and excessive GI adverse effects. Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

Orforglipron

Oral Small-Molecule GLP-1 Receptor Agonist | Weight Loss & Diabetes

Small-molecule GLP-1 receptor agonist with biased signaling preferentially activating G protein/cAMP pathways, enhancing insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite while minimizing receptor desensitization. 79.

Half-life: 25-68 hours Typical dose: Start 3-6mg daily, titrate up to 12-36mg based on response weight loss, metabolic
glp1 receptor teratogenic
View full profile

Semaglutide

GLP-1 Receptor Agonist | Weight Loss & Diabetes

Mimics native GLP-1, binding to receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic pathways..

Half-life: ~7 days (168 hours) Typical dose: 0.25mg starting, titrate to 1-2.4mg weekly weight loss, metabolic
glp1 receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Orforglipron, Semaglutide). Monitor accordingly.

Frequently Asked Questions

Can I take Orforglipron with Semaglutide?

Combining Orforglipron with Semaglutide is not recommended. Both are GLP-1 agonists; combining increases severe hypoglycemia and excessive GI adverse effects.

Is Orforglipron and Semaglutide safe together?

This combination carries significant risk. Both are GLP-1 agonists; combining increases severe hypoglycemia and excessive GI adverse effects. Consult a healthcare professional before combining.

What are the interactions between Orforglipron and Semaglutide?

Both are GLP-1 agonists; combining increases severe hypoglycemia and excessive GI adverse effects. This assessment has 95% confidence and is based on documented research data.

How should I time Orforglipron and Semaglutide?

Orforglipron has a half-life of 25-68 hours and Semaglutide has a half-life of ~7 days (168 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Orforglipron vs Semaglutide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.